Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
We investigated the effect of a continuous infusion (50 micrograms as an initial bolus followed by a maintenance infusion at a rate of 0.1 micrograms/min.kg body wt for 45 min) of synthetic human atrial natriuretic factor (hANF) on renal hemodynamics and the renin-angiotensin-aldosterone system in 15 cirrhotic patients with ascites. Basal hANF levels were higher in cirrhotic patients when compared with normal values. Human atrial natriuretic factor infusion induced a significant decrease in mean blood pressure (from 77.8 +/- 1.1 to 68.6 +/- 1.5 mmHg, p less than 0.001) and a significant increase in heart rate (from 76.4 +/- 2.7 to 89.8 +/- 2.4 beats/min, p less than 0.001) in the patients studied. A remarkable increase in natriuresis (i.e., greater than or equal to 200 muEq/min) was observed in 5 patients (responders), whereas the infusion did not modify sodium excretion (i.e., less than or equal to 20 muEq/min) in 6 patients (nonresponders) and induced an intermediate response in 4 patients. Human atrial natriuretic factor-induced natriuresis was related to changes in renal hemodynamics that occurred during hANF infusion. In responders, the extent of the natriuretic response paralleled the increase of effective renal plasma flow and glomerular filtration rate; in non-responders the absent natriuretic response was associated with an evident reduction of these parameters. The reduction of blood pressure was similar in responders and nonresponders, but in the latter group it was followed by a marked increase of plasma renin activity and heart rate. It is likely that in nonresponders the natriuretic effect of hANF was blunted by the hemodynamic and hormonal changes triggered by the concomitant hANF-induced hypotension. This probably occurs in the presence of a greater reduction of effective arterial blood volume, as suggested by the higher baseline levels of plasma renin activity and the inability to increase free water excretion after a water load observed in nonresponders.
Laffi
G
G
Istituto di Clinica Medica II, University of Florence School of Medicine, Italy.
Pinzani
M
M
Meacci
E
E
La Villa
G
G
Renzi
D
D
Baldi
E
E
Cominelli
F
F
Marra
F
F
Gentilini
P
P
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D001201:Ascites / Q000209:etiology; D009320:Atrial Natriuretic Factor / Q000008:administration & dosage* / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D005260:Female; D005919:Glomerular Filtration Rate; D006439:Hemodynamics; D006801:Humans; D007262:Infusions, Intravenous; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications / Q000503:physiopathology* / Q000652:urine; D008297:Male; D008875:Middle Aged; D012079:Renal Circulation; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine
C472955:NPPA protein, human; D000450:Aldosterone; D009320:Atrial Natriuretic Factor; D012964:Sodium; D012083:Renin; D006152:Cyclic GMP